Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Avricore Health Inc V.AVCR

Alternate Symbol(s):  AVCRF

Avricore Health Inc. is a pharmacy service innovator focused on acquiring and developing early-stage technologies aimed at advancing pharmacy practice and patient care. The Company is involved in the business of health data and point-of-care technologies (POCT). HealthTab, its flagship offering, is a turnkey point-of-care testing solution that combines point-of-care technologies with a secure, cloud-based platform for tackling pressing global health issues. With just a few drops of blood from a finger prick, the system generates lab-accurate results on the spot and data is reported in real time. The test menu includes up to 23 key biomarkers for screening and managing chronic diseases, such as diabetes and heart disease (e.g., HbA1c, Lipid Profile, eGFR). The HealthTab also has capabilities for bacterial and viral tests, such as strep and COVID-19. The HealthTab platform transforms pharmacies into community point-of-care diagnostic centers.


TSXV:AVCR - Post by User

Bullboard Posts
Post by kingposton Mar 31, 2016 1:26pm
212 Views
Post# 24716038

Short term industry sentiment is not material IMO...

Short term industry sentiment is not material IMO...The B.C. and J.D. of the world, and many other specialty Canadian pharma fund managers have had their heads handed to them on smallish medical plays in the last six monthes and so, and as a result  they are not leading the charge anymore/currently (meaning accumulating then promote)  .... just listen to them speak, and their top picks now are  oftem big Industrial cos and when asked about certain pharma cos their voices get shakey now...... We would be way higher now if it was not for this  much altered industry sentiment, as the players are stunned right now.....
I do not mind either way here , what the current sentiment is, as IMO this is at least a one year plus investment.... and any dips in sentiment give retail and others a chance to buy  at great value... The very large runway (of growth potential) for NPH will just get bigger, and even a few years out, the runway will be eye opening ...
Last word to the wise, is I expect this stock to be manipulated by groups along the way (this is the norm rather than the exception) ... For example, I expect them to try to trick retail into trading the stock, which will give them an opportuntiy at any time, along the way,  to wipe out a big swath of retail on one swing...and also this mentality will be used for "them" to profit on a short term basis while always having the op to wipe out retail in one time event..... 
Bullboard Posts